Company profile
Speedus Corp.
OTC: SPDE · Healthcare · Medical - Diagnostics & Research
#938 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 44
v0.1 · 5/100 weight · pillars only
↑ listing tenure, revenue growth (YoY) · ↓ market scale, return on equity
Methodology →Revenue TTM
$461.2k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.8M
Employees
20
as of 2026-08-03
Market cap
$416
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$461.2k$461.2k2009
Net income-$2.8M-$2.8M2009
Operating income-$3.5M-$3.5M2009
Total assets$2.1M$2.1M2009
Liabilities$1.9M$1.9M2009
Equity$787.8k$787.8k2009
Revenue trend
FY2002 – FY2009 · USD
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Speedus Corp.’s revenue?
Speedus Corp. booked $461.2k in FY2009 revenue, growing 196% year over year — faster than most Healthcare companies we track, at a -616.6% net margin.
Peers · Healthcare
Bioelectronics Corporation——Pasithea Therapeutics Corp.32DPositron Corporation28DMangoceuticals, Inc.30DIntegrative Health Technologies, Inc.——Alternate Health Corp.——Neighbors
Monmouth →Key facts
CEOShant S. Hovnanian
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersFreehold, NJ
ExchangeOTC: SPDE
Employees20
IPO date1996-02-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.